These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8498902)

  • 1. Biochemical definition of the uremic syndrome and possible therapeutic implications.
    Vanholder R; Hsu C; Ringoir S
    Artif Organs; 1993 Apr; 17(4):234-9. PubMed ID: 8498902
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible relation between restless legs and anaemia in renal dialysis patients.
    Roger SD; Harris DC; Stewart JH
    Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of erythropoietin on endothelin release in uremia.
    Nurol A; Bahattin A; Tolga K; Tekin A; Abdülkerim B
    Nephron; 1996; 72(4):728-9. PubMed ID: 8730461
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of recombinant human erythropoietin on growth hormone responses to growth hormone releasing hormone in uremic patients.
    Díez JJ; Iglesias P; Selgas R
    Clin Nephrol; 1994 Feb; 41(2):119. PubMed ID: 8004829
    [No Abstract]   [Full Text] [Related]  

  • 6. rhEPO treatment of anemia in uremic patients.
    Bommer J; Barth HP; Schwöbel B
    Contrib Nephrol; 1990; 87():59-67. PubMed ID: 2093542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treating uremia anemia with human recombinant erythropoietin].
    Litwin M; Grenda R; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):132-4. PubMed ID: 8090664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent findings on the pathogenesis and therapy of anemia in chronic kidney failure].
    Moccia F; Morra L; Gurreri G
    Recenti Prog Med; 1992 Oct; 83(10):572-6. PubMed ID: 1462041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.
    Buemi M; Allegra A; Laganà A; Aloisi C; Privitera M; Morabito N; Frisina N
    Riv Eur Sci Med Farmacol; 1993; 15(5-6):195-7. PubMed ID: 7761669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant human erythropoietin in uremic patients in substitute treatment].
    Canaud B; Mion C
    Rev Prat; 1992 Feb; 42(4):432-40. PubMed ID: 1604162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 13. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment.
    Cannella G; Guerra UP; Sandrini M; Gaggiotti M; Traverso GB; Rolla D; Marsano L; Mulas D
    Clin Nephrol; 1993 Sep; 40(3):164-7. PubMed ID: 8403572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
    Buccianti G; Colombi L; Battistel V
    Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immunoglobulin production in dialysis patients treated with recombinant erythropoietin.
    Schaefer RM; Paczek L; Berthold G; Gilge U; Heidland A
    Int J Artif Organs; 1992 Apr; 15(4):204-8. PubMed ID: 1587641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does anemia correction by rHuEPO improve uremic cardiopathy?
    Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
    Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of rHuEPO in treatment of uremic anemia prior to end-stage renal disease.
    Koene RA; Frenken LA
    Kidney Int Suppl; 1992 Oct; 38():S142-7. PubMed ID: 1405365
    [No Abstract]   [Full Text] [Related]  

  • 20. L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
    Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W
    Nephron; 1999; 83(4):370-1. PubMed ID: 10575305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.